CicaHuntek Chemical (6725.TWO) Q1 2025 Earnings Report

CicaHuntek Chemical Technology Taiwan reports QQ1 2025 revenue of TWD 701.97 million, down 15.6% year-over-year and 57.5% quarter-over-quarter, with a gross profit of TWD 148.63 million and a gross margin of 21.17%. EBITDA was TWD 111.86 million and net income came in at TWD 83.40 million (EPS 2.53), yielding an operating margin of 12.91% and an EBITDA margin of 15.94%. The quarter shows earnings durability despite a sharp top-line pullback, driven by disciplined cost management and a stable operating framework in a cyclically sensitive industrial machinery market.

Financial flexibility remains a strength. The company ended QQ1 2025 with cash and cash equivalents plus short-term investments of about TWD 950.37 million and a net debt position of roughly TWD 126.21 million. The balance sheet reflects solid liquidity (current ratio 1.90, quick ratio 1.36) and a moderated leverage posture (debt ratio 0.187, debt-to-equity 0.399). However, operating cash flow was negative (CFO -55.83 million) as working capital consumed cash (change in working capital -149.23 million; receivables and inventory rose by approximately 43.57 million and 93.98 million respectively). Free cash flow was negative at -56.35 million, underscoring near-term cash-flow sensitivity to working capital movements.

Looking forward, management did not issue formal forward guidance in the QQ1 2025 release. The near-term trajectory will hinge on order intake, project timing, and capital expenditure cycles in Asia, as well as ongoing efficiency initiatives and raw-material dynamics. Investors should monitor backlog development, customer capex cycles, and the company’s ability to translate earnings into positive free cash flow as volumes normalize.